ECRI Institute Technology Assessment Policy Conference 2009

2009 年 ECRI 研究所技术评估政策会议

• 批准号: 7811392
• 负责人: Jeffrey Charles Lerner
• 金额: $ 5万
• 依托单位: ECRI INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-30 至 2010-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7811392
• 关键词: ECRI; Institute; Technology; Assessment; Policy

DESCRIPTION (PROVIDED BY APPLICANT): ECRI Institute, an independent nonprofit organization, dedicates itself to bringing the discipline of applied scientific research to healthcare to uncover the best approaches to improving patient care. As pioneers in this science for nearly 40 years, ECRI Institute marries experience and independence with the objectivity of evidence-based research. ECRI Institute is designated a Collaborating Center of the World Health Organization and an Evidence-based Practice Center (EPC) by the Agency for Healthcare Research and Quality (AHRQ). ECRI Institute has planned and conducted sixteen annual conferences that address issues of vital importance in the use of evidence in policy and practice. Each of our sixteen conferences has been focused on topics of great interest and importance to AHRQ. The 2009 conference, "Comparative Effectiveness and Personalized Medicine: An Uneasy but Essential Interface," is programmatically linked to last year's conference on comparative effectiveness. These events are constructed like collaboratively edited books aimed at telling a story behind an emerging issue that is important for policy and practice, and that needs the support of rigorous methodologies to bring evidence into the deliberations. The 2007 and the 2008 ECRI conferences, and the one planned for 2009, all address different, critical aspects of comparative effectiveness. They should be seen as three parts of an effort to provide a fuller understanding of key issues in comparative effectiveness for policymakers and practitioners in the public and private sectors. The 2009 conference will consist of three sections: 1) clinical technologies; 2) IT technologies; and 3) behavioral aspects of using these technologies. Science, public demand, and industry perspectives will all be addressed. The difficulties posed by "personalized" technology assessment pose a challenge to the evolving field of comparative effectiveness and to the national effort to make comparative effectiveness a more robust part of the healthcare system. Conference participants in the past, and expected to participate in 2009, include senior executives, clinicians, and researchers from health plans and insurers, provider organizations, employers, pharmaceutical companies, medical device manufacturers, research organizations and consumer groups, and State and Federal government agencies, as well as elected officials and members of the judiciary. PUBLIC HEALTH RELEVANCE: ECRI Institute has planned and conducted sixteen annual conferences that address issues of vital importance in the use of evidence in policy and practice. Each of our sixteen conferences has been focused on topics of great interest and importance to AHRQ. The 2009 conference, "Comparative Effectiveness and Personalized Medicine: An Uneasy but Essential Interface," is programmatically linked to ECRI last two conferences on comparative effectiveness. These events are constructed like collaboratively edited books aimed at telling a story behind an emerging issue that is important for policy and practice, and that needs the support of rigorous methodologies to bring evidence into the deliberations. The 2007 and the 2008 ECRI conferences, and the one planned for 2009, all address different, critical aspects of comparative effectiveness. They should be seen as three parts of an effort to provide a fuller understanding of key issues in comparative effectiveness for policymakers and practitioners in the public and private sectors.

描述（由申请人提供）：ECRI研究所是一个独立的非营利组织，致力于将应用科学研究的学科带到医疗保健领域，以发现改善患者护理的最佳方法。作为这一科学领域近40年的先驱，ECRI研究所将经验和独立性与循证研究的客观性结合起来。ECRI研究所被指定为世界卫生组织的合作中心和医疗保健研究和质量机构（AHRQ）的循证实践中心（EPC）。ECRI研究所计划并举办了16次年度会议，讨论在政策和实践中使用证据的至关重要的问题。我们的16个会议中的每一个都集中在AHRQ非常感兴趣和重要的主题上。 2009年的会议，“比较有效性和个性化医疗：一个不安，但必不可少的接口，”是编程连接到去年的比较有效性会议。这些活动就像是合作编辑的书籍，旨在讲述一个新出现的问题背后的故事，这个问题对政策和实践很重要，需要严格的方法支持，以便将证据纳入审议。2007年和2008年的欧洲反对种族主义和不容忍委员会会议，以及计划于2009年举行的会议，都讨论了相对有效性的不同关键方面。应将它们视为一项努力的三个部分，以便使公共和私营部门的决策者和从业人员更充分地了解相对有效性方面的关键问题。 2009年会议将包括三个部分：1）临床技术; 2）IT技术; 3）使用这些技术的行为方面。科学，公众需求和行业观点都将得到解决。“个性化”技术评估带来的困难对不断发展的比较有效性领域和国家努力使比较有效性成为医疗保健系统更强大的一部分提出了挑战。过去的会议参与者，预计将在2009年参加，包括高级管理人员，临床医生和研究人员从健康计划和保险公司，供应商组织，雇主，制药公司，医疗设备制造商，研究组织和消费者团体，以及州和联邦政府机构，以及当选官员和司法机构的成员。 公共卫生关系：ECRI研究所计划并举办了16次年度会议，讨论在政策和实践中使用证据的至关重要的问题。我们的16个会议中的每一个都集中在AHRQ非常感兴趣和重要的主题上。2009年的会议，“比较有效性和个性化医疗：一个不安，但必不可少的接口，”是编程连接到ECRI的最后两个会议的比较有效性。这些活动就像是合作编辑的书籍，旨在讲述一个新出现的问题背后的故事，这个问题对政策和实践很重要，需要严格的方法支持，以便将证据纳入审议。2007年和2008年的欧洲反对种族主义和不容忍委员会会议，以及计划于2009年举行的会议，都讨论了相对有效性的不同关键方面。应将它们视为一项努力的三个部分，以便使公共和私营部门的决策者和从业人员更充分地了解相对有效性方面的关键问题。